These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36261091)

  • 1. Discovery of a potent Guanidine derivative that selectively binds and stabilizes the human BCL-2 G-quadruplex DNA and downregulates the transcription.
    Pandya N; Rani R; Kumar V; Kumar A
    Gene; 2023 Jan; 851():146975. PubMed ID: 36261091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA G-Quadruplex in Human Telomeres and Oncogene Promoters: Structures, Functions, and Small Molecule Targeting.
    Chen L; Dickerhoff J; Sakai S; Yang D
    Acc Chem Res; 2022 Sep; 55(18):2628-2646. PubMed ID: 36054116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-quadruplex-mediated specific recognition, stabilization and transcriptional repression of bcl-2 by small molecule.
    Pandya N; Singh M; Rani R; Kumar V; Kumar A
    Arch Biochem Biophys; 2023 Jan; 734():109483. PubMed ID: 36513132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dihydroindolizino indole derivative selectively stabilizes G-quadruplex DNA and down-regulates c-MYC expression in human cancer cells.
    Nagesh N; Raju G; Srinivas R; Ramesh P; Reddy MD; Reddy ChR
    Biochim Biophys Acta; 2015 Jan; 1850(1):129-40. PubMed ID: 25452213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperine analogs arrest c-myc gene leading to downregulation of transcription for targeting cancer.
    Pandya N; Kumar A
    Sci Rep; 2021 Nov; 11(1):22909. PubMed ID: 34824301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A newly identified G-quadruplex as a potential target regulating Bcl-2 expression.
    Sun H; Xiang J; Shi Y; Yang Q; Guan A; Li Q; Yu L; Shang Q; Zhang H; Tang Y; Xu G
    Biochim Biophys Acta; 2014 Oct; 1840(10):3052-7. PubMed ID: 25086254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ion Binding Properties and Dynamics of the
    Ratnasinghe BD; Salsbury AM; Lemkul JA
    J Chem Inf Model; 2020 Dec; 60(12):6476-6488. PubMed ID: 33264004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectroscopy probing of the formation, recognition, and conversion of a G-quadruplex in the promoter region of the bcl-2 oncogene.
    Li H; Liu Y; Lin S; Yuan G
    Chemistry; 2009; 15(10):2445-52. PubMed ID: 19156807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
    Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chelerythrine down regulates expression of VEGFA, BCL2 and KRAS by arresting G-Quadruplex structures at their promoter regions.
    Jana J; Mondal S; Bhattacharjee P; Sengupta P; Roychowdhury T; Saha P; Kundu P; Chatterjee S
    Sci Rep; 2017 Jan; 7():40706. PubMed ID: 28102286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of 2,9-disubstituted-1,10-phenanthroline derivatives as G-quadruplex binders.
    Figueiredo J; Carreira-Barral I; Quesada R; Mergny JL; Cruz C
    Bioorg Med Chem; 2022 Nov; 73():116971. PubMed ID: 36208542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex.
    Dutta D; Debnath M; Müller D; Paul R; Das T; Bessi I; Schwalbe H; Dash J
    Nucleic Acids Res; 2018 Jun; 46(11):5355-5365. PubMed ID: 29762718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing G4-Binding Ligands In Vitro and in Cellulo Using Dimeric Carbocyanine Dye Displacement Assay.
    Desai N; Shah V; Datta B
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33807659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of G-quadruplex topology through hybrid binding with implications in cancer theranostics.
    Suseela YV; Satha P; Murugan NA; Govindaraju T
    Theranostics; 2020; 10(23):10394-10414. PubMed ID: 32929356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
    Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
    Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase Inhibition and Human Telomeric G-Quadruplex DNA Stabilization by a β-Carboline-Benzimidazole Derivative at Low Concentrations.
    Yadav K; Meka PNR; Sadhu S; Guggilapu SD; Kovvuri J; Kamal A; Srinivas R; Devayani P; Babu BN; Nagesh N
    Biochemistry; 2017 Aug; 56(33):4392-4404. PubMed ID: 28737386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Telomeric G-Quadruplex Selective Fluoro-Isoquinolines Induce Apoptosis in Cancer Cells.
    Maiti S; Saha P; Das T; Bessi I; Schwalbe H; Dash J
    Bioconjug Chem; 2018 Apr; 29(4):1141-1154. PubMed ID: 29433312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-quadruplex structures in the human genome as novel therapeutic targets.
    Bidzinska J; Cimino-Reale G; Zaffaroni N; Folini M
    Molecules; 2013 Oct; 18(10):12368-95. PubMed ID: 24108400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparative Docking Strategy to Identify Polyphenolic Derivatives as Promising Antineoplastic Binders of G-quadruplex DNA c-myc and bcl-2 Sequences.
    Costa G; Rocca R; Moraca F; Talarico C; Romeo I; Ortuso F; Alcaro S; Artese A
    Mol Inform; 2016 Sep; 35(8-9):391-402. PubMed ID: 27546043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-quadruplexes unfolding by RHAU helicase.
    Gueddouda NM; Mendoza O; Gomez D; Bourdoncle A; Mergny JL
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1382-1388. PubMed ID: 28065761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.